Daily News Podcast

Valsartan cancer risk is low

Publish date: July 31, 2018

 

The FDA says that cancer risk associated with NDMA contained in impure valsartan is definitely real, but it is very low. Also today, drinking during pregnancy could impact cognition, sexual function counseling should start early, and those with HIV develop more frailty. Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Telemedicine payment expansion?
MDedge Dermatology
Bundle pay plan didn’t save money
MDedge Dermatology
Brain damage, slight benefit seen in epinephrine cardiac arrest
MDedge Dermatology
Is fibromyalgia one disorder – or two?
MDedge Dermatology
Is fish oil’s heart benefit a fish tale?
MDedge Dermatology
Blood pressure meds cut cognitive impairment risk
MDedge Dermatology
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Dermatology
Study explores adolescents’ views on their skin tone, pressure to tan
MDedge Dermatology
Oral drug seen preventing angioedema attacks
MDedge Dermatology
Free skin cancer screening highlights need
MDedge Dermatology